The Renin–Angiotensin System and Cardiovascular–Kidney–Metabolic Syndrome: Focus on Early-Life Programming
International Journal of Molecular Sciences · 14.03.2024 · 25 (6) · 3298
DOI: 10.3390/ijms25063298 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 14.03.2024. Verfasst von You-Lin Tain und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Nephrology, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 833, Taiwan. Hauptthemen laut MEDLINE: Metabolic Syndrome, Cardiovascular System, Hypertension. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 159 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.
Abstract (Originalsprache)
The identification of pathological links among metabolic disorders, kidney ailments, and cardiovascular conditions has given rise to the concept of cardiovascular–kidney–metabolic (CKM) syndrome. Emerging prenatal risk factors seem to increase the likelihood of CKM syndrome across an individual’s lifespan. The renin–angiotensin system (RAS) plays a crucial role in maternal–fetal health and maintaining homeostasis in cardiovascular, metabolic, and kidney functions. This review consolidates current preclinical evidence detailing how dysregulation of the RAS during pregnancy and lactation leads to CKM characteristics in offspring, elucidating the underlying mechanisms. The multi-organ effects of RAS, influencing fetal programming and triggering CKM traits in offspring, suggest it as a promising reprogramming strategy. Additionally, we present an overview of interventions targeting the RAS to prevent CKM traits. This comprehensive review of the potential role of the RAS in the early-life programming of CKM syndrome aims to expedite the clinical translation process, ultimately enhancing outcomes in cardiovascular–kidney–metabolic health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Pediatric Nephrology, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 833, Taiwan.
- College of Medicine, Chang Gung University, Taoyuan 333, Taiwan.
- Institute for Translational Research in Biomedicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 833, Taiwan.
- Department of Pharmacy, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 833, Taiwan.
- School of Pharmacy, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
ORCID-Profile: You-Lin Tain, Chien-Ning Hsu
Förderung
- Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan
Zitieren
APA
Tain, Y. L., & Hsu, C. N. (2024). The Renin–Angiotensin System and Cardiovascular–Kidney–Metabolic Syndrome: Focus on Early-Life Programming. International Journal of Molecular Sciences, 25(6), 3298. https://doi.org/10.3390/ijms25063298
Vancouver
Tain YL, Hsu CN. The Renin–Angiotensin System and Cardiovascular–Kidney–Metabolic Syndrome: Focus on Early-Life Programming. International Journal of Molecular Sciences. 2024;25(6):3298. doi:10.3390/ijms25063298
BibTeX
@article{Tain2024,
author = {Tain, You-Lin and Hsu, Chien-Ning},
title = {The Renin–Angiotensin System and Cardiovascular–Kidney–Metabolic Syndrome: Focus on Early-Life Programming},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {6},
pages = {3298},
doi = {10.3390/ijms25063298}
}
EUVIMED